SI-BONE finance chief sells 6,380 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Anshul Maheshwari, SI-BONE, Inc.’s Chief Op & Financial Officer, reported three direct common-stock sales totaling 6,380 shares on November 16–17, 2026. On November 16, he sold 2,476 shares at a weighted average of $23.3123 and 2,189 shares at $23.3368; both sales covered tax withholding tied to restricted stock unit vesting and were not discretionary trades. On November 17, he sold 1,715 shares at a weighted average of $23.1888 under a Rule 10b5-1 trading plan dated December 17, 2025.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F4, F5, F6 | 1,715 | $23.1888 | $40K |
| Sale | Common Stock F1, F2 | 2,476 | $23.3123 | $58K |
| Sale | Common Stock F1, F3 | 2,189 | $23.3368 | $51K |
Footnotes (6)
- F1. The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- F2. This transaction was executed in multiple trades at prices ranging from $23.23 USD to $23.37 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. This transaction was executed in multiple trades at prices ranging from $23.21 USD to $23.43 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated December 17, 2025.
- F5. This transaction was executed in multiple trades at prices ranging from $23.03 USD to $23.43 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. Includes 151,286 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
restricted stock units financial
sell to cover financial
weighted average sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Were Anshul Maheshwari’s SIBN stock sales discretionary or under a trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.